_id
6911c9daccc777a4e85d6705
Ticker
IBO
Name
Impact BioMedical, Inc.
Exchange
AMEX
Address
1400 Broadfield Blvd., Houston, TX, United States, 77084
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.impactbiomedinc.com
Description
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS, Inc.
Last Close
0.499
Volume
83321
Current Price
0.49745
Change
0.0135
Last Updated
2026-01-04T14:55:39.056Z
Image
data:image/webp;base64,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
Ipo Date
2024-09-16T00:00:00.000Z
Market Cap
54246104
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
18000
Cost Of Revenue
1000
Gross Profit
17000
Operating Expenses
12000
Operating Income
5000
Interest Expense
262000
Pretax Income
-1475000
Net Income
-1470000
Eps
-0.12063605235506193
Dividends Per Share
-
Shares Outstanding
104621231
Income Tax Expense
-5000
EBITDA
-925000
Operating Margin
27.77777777777778
Total Other Income Expense Net
-1480000
Cash
12000
Short Term Investments
-
Receivables
214000
Inventories
485000
Total Current Assets
917000
Property Plant Equipment
13000
Total Assets
18208000
Payables
576000
Short Term Debt
22881000
Long Term Debt
0
Total Liabilities
27061000
Equity
-11809000
Bs_currency_symbol
USD
Depreciation
859000
Change In Working Capital
852000
Cash From Operations
-1989000
Capital Expenditures
0
Cash From Investing
2000
Cash From Financing
0
Net Change In Cash
-1987000
Cf_currency_symbol
USD
PE
-
PB
-0.5133062240155813
ROE
12.448132780082988
ROA
-8.073374340949032
FCF
-1989000
Fcf Percent
-110.5
Piotroski FScore
0
Health Score
24
Deep Value Investing Score
1
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
18000
Quarters > 0 > income Statement > cost Of Revenue
1000
Quarters > 0 > income Statement > gross Profit
17000
Quarters > 0 > income Statement > operating Expenses
12000
Quarters > 0 > income Statement > operating Income
5000
Quarters > 0 > income Statement > interest Expense
262000
Quarters > 0 > income Statement > pretax Income
-1475000
Quarters > 0 > income Statement > net Income
-1470000
Quarters > 0 > income Statement > eps
-0.12063605235506193
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12185412
Quarters > 0 > income Statement > income Tax Expense
-5000
Quarters > 0 > income Statement > EBITDA
-925000
Quarters > 0 > income Statement > operating Margin
27.77777777777778
Quarters > 0 > income Statement > total Other Income Expense Net
-1480000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
12000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
214000
Quarters > 0 > balance Sheet > inventories
485000
Quarters > 0 > balance Sheet > total Current Assets
917000
Quarters > 0 > balance Sheet > property Plant Equipment
13000
Quarters > 0 > balance Sheet > total Assets
18208000
Quarters > 0 > balance Sheet > payables
576000
Quarters > 0 > balance Sheet > short Term Debt
22881000
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
27061000
Quarters > 0 > balance Sheet > equity
-11809000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-17105000
Quarters > 0 > cash Flow > depreciation
859000
Quarters > 0 > cash Flow > change In Working Capital
852000
Quarters > 0 > cash Flow > cash From Operations
-1989000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
2000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1987000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.12063605235506193
Quarters > 0 > ratios > PB
-0.5133062240155813
Quarters > 0 > ratios > ROE
12.448132780082988
Quarters > 0 > ratios > ROA
-8.073374340949032
Quarters > 0 > ratios > FCF
-1989000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-110.5
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
7000
Quarters > 1 > income Statement > cost Of Revenue
11000
Quarters > 1 > income Statement > gross Profit
-4000
Quarters > 1 > income Statement > operating Expenses
1149000
Quarters > 1 > income Statement > operating Income
-1153000
Quarters > 1 > income Statement > interest Expense
260000
Quarters > 1 > income Statement > pretax Income
-14352000
Quarters > 1 > income Statement > net Income
-14346000
Quarters > 1 > income Statement > eps
-1.1773093925753189
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12185412
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-13804000
Quarters > 1 > income Statement > operating Margin
-16471.428571428572
Quarters > 1 > income Statement > total Other Income Expense Net
-13199000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
624000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
200000
Quarters > 1 > balance Sheet > inventories
486000
Quarters > 1 > balance Sheet > total Current Assets
1481000
Quarters > 1 > balance Sheet > property Plant Equipment
14000
Quarters > 1 > balance Sheet > total Assets
19060000
Quarters > 1 > balance Sheet > payables
554000
Quarters > 1 > balance Sheet > short Term Debt
22352000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
26440000
Quarters > 1 > balance Sheet > equity
-10341000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-15631000
Quarters > 1 > cash Flow > depreciation
571000
Quarters > 1 > cash Flow > change In Working Capital
548000
Quarters > 1 > cash Flow > cash From Operations
-1376000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
1000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-1375000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.1773093925753189
Quarters > 1 > ratios > PB
-0.5861747606034232
Quarters > 1 > ratios > ROE
138.72932985204525
Quarters > 1 > ratios > ROA
-75.26757607555089
Quarters > 1 > ratios > FCF
-1376000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-196.57142857142858
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
283000
Quarters > 2 > income Statement > gross Profit
-283000
Quarters > 2 > income Statement > operating Expenses
727000
Quarters > 2 > income Statement > operating Income
-1010000
Quarters > 2 > income Statement > interest Expense
271000
Quarters > 2 > income Statement > pretax Income
-1278000
Quarters > 2 > income Statement > net Income
-1267000
Quarters > 2 > income Statement > eps
-0.10503415350886611
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12062743
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-724000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-268000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1318000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
204000
Quarters > 2 > balance Sheet > inventories
489000
Quarters > 2 > balance Sheet > total Current Assets
2183000
Quarters > 2 > balance Sheet > property Plant Equipment
16000
Quarters > 2 > balance Sheet > total Assets
20051000
Quarters > 2 > balance Sheet > payables
615000
Quarters > 2 > balance Sheet > short Term Debt
9141000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
13241000
Quarters > 2 > balance Sheet > equity
3843000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1823
Quarters > 2 > cash Flow > depreciation
407.2
Quarters > 2 > cash Flow > change In Working Capital
156.84
Quarters > 2 > cash Flow > cash From Operations
-981
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
1000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-977
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.10503415350886611
Quarters > 2 > ratios > PB
1.5614393716757742
Quarters > 2 > ratios > ROE
-32.96903460837887
Quarters > 2 > ratios > ROA
-6.318886838561667
Quarters > 2 > ratios > FCF
-981
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
279000
Quarters > 3 > income Statement > gross Profit
-279000
Quarters > 3 > income Statement > operating Expenses
26231000
Quarters > 3 > income Statement > operating Income
-26231000
Quarters > 3 > income Statement > interest Expense
270000
Quarters > 3 > income Statement > pretax Income
-27100000
Quarters > 3 > income Statement > net Income
-27108000
Quarters > 3 > income Statement > eps
-2.355374055087323
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11509000
Quarters > 3 > income Statement > income Tax Expense
33000
Quarters > 3 > income Statement > EBITDA
-26551000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-869000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1999000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
184000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2448000
Quarters > 3 > balance Sheet > property Plant Equipment
17000
Quarters > 3 > balance Sheet > total Assets
20290000
Quarters > 3 > balance Sheet > payables
713000
Quarters > 3 > balance Sheet > short Term Debt
8878000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
13053000
Quarters > 3 > balance Sheet > equity
4259000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-38983743
Quarters > 3 > cash Flow > depreciation
401227
Quarters > 3 > cash Flow > change In Working Capital
-592493
Quarters > 3 > cash Flow > cash From Operations
-1806241
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
2000
Quarters > 3 > cash Flow > cash From Financing
844158
Quarters > 3 > cash Flow > net Change In Cash
-962082
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.355374055087323
Quarters > 3 > ratios > PB
1.344247957266964
Quarters > 3 > ratios > ROE
-636.4874383658135
Quarters > 3 > ratios > ROA
-133.60275998028587
Quarters > 3 > ratios > FCF
-1806241
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2331028
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
2331028
Annuals > 0 > income Statement > operating Expenses
1779364
Annuals > 0 > income Statement > operating Income
551664
Annuals > 0 > income Statement > interest Expense
168948
Annuals > 0 > income Statement > pretax Income
-2051587
Annuals > 0 > income Statement > net Income
-2051587
Annuals > 0 > income Statement > eps
-0.04913451480125566
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
41754498
Annuals > 0 > income Statement > income Tax Expense
33
Annuals > 0 > income Statement > EBITDA
-1539177
Annuals > 0 > income Statement > operating Margin
23.666124988631626
Annuals > 0 > income Statement > total Other Income Expense Net
-2603251
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1999000
Annuals > 0 > balance Sheet > short Term Investments
1997001
Annuals > 0 > balance Sheet > receivables
184000
Annuals > 0 > balance Sheet > inventories
-265
Annuals > 0 > balance Sheet > total Current Assets
2448000
Annuals > 0 > balance Sheet > property Plant Equipment
17000
Annuals > 0 > balance Sheet > total Assets
20290000
Annuals > 0 > balance Sheet > payables
713000
Annuals > 0 > balance Sheet > short Term Debt
8878000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
13053000
Annuals > 0 > balance Sheet > equity
4259000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-35532327
Annuals > 0 > cash Flow > depreciation
1609222
Annuals > 0 > cash Flow > change In Working Capital
-874358
Annuals > 0 > cash Flow > cash From Operations
-5635874
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
2876
Annuals > 0 > cash Flow > cash From Financing
8506302
Annuals > 0 > cash Flow > net Change In Cash
2873303
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.04913451480125566
Annuals > 0 > ratios > PB
5.083284154261563
Annuals > 0 > ratios > ROE
-48.17062690772482
Annuals > 0 > ratios > ROA
-10.11132084770823
Annuals > 0 > ratios > FCF
-5635874
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.4177633215903027
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1029989
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
1029989
Annuals > 1 > income Statement > operating Expenses
4028000
Annuals > 1 > income Statement > operating Income
-4028000
Annuals > 1 > income Statement > interest Expense
444000
Annuals > 1 > income Statement > pretax Income
-4407000
Annuals > 1 > income Statement > net Income
-4336000
Annuals > 1 > income Statement > eps
-0.02266617620044494
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
191298257
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-2843000
Annuals > 1 > income Statement > operating Margin
-391.0721376636061
Annuals > 1 > income Statement > total Other Income Expense Net
-379000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
331000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
332000
Annuals > 1 > balance Sheet > property Plant Equipment
287000
Annuals > 1 > balance Sheet > total Assets
44633000
Annuals > 1 > balance Sheet > payables
832000
Annuals > 1 > balance Sheet > short Term Debt
12074000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
16371000
Annuals > 1 > balance Sheet > equity
25222000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4407000
Annuals > 1 > cash Flow > depreciation
1120000
Annuals > 1 > cash Flow > change In Working Capital
436000
Annuals > 1 > cash Flow > cash From Operations
-2851000
Annuals > 1 > cash Flow > capital Expenditures
18000
Annuals > 1 > cash Flow > cash From Investing
-15000
Annuals > 1 > cash Flow > cash From Financing
2865000
Annuals > 1 > cash Flow > net Change In Cash
-1000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.02266617620044494
Annuals > 1 > ratios > PB
3.9326043237847905
Annuals > 1 > ratios > ROE
-17.191340892871303
Annuals > 1 > ratios > ROA
-9.714785024533416
Annuals > 1 > ratios > FCF
-2869000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.7854666409058737
Annuals > 1 > health Score
25
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
50000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
50000
Annuals > 2 > income Statement > operating Expenses
3454000
Annuals > 2 > income Statement > operating Income
-3404000
Annuals > 2 > income Statement > interest Expense
462000
Annuals > 2 > income Statement > pretax Income
-7876000
Annuals > 2 > income Statement > net Income
-7051000
Annuals > 2 > income Statement > eps
-0.6132529253886624
Annuals > 2 > income Statement > dividends Per Share
410000
Annuals > 2 > income Statement > shares Outstanding
11497703
Annuals > 2 > income Statement > income Tax Expense
-621000
Annuals > 2 > income Statement > EBITDA
-6301000
Annuals > 2 > income Statement > operating Margin
-6808
Annuals > 2 > income Statement > total Other Income Expense Net
-4472000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
16000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
122000
Annuals > 2 > balance Sheet > property Plant Equipment
276000
Annuals > 2 > balance Sheet > total Assets
46497000
Annuals > 2 > balance Sheet > payables
539000
Annuals > 2 > balance Sheet > short Term Debt
9991000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
13828000
Annuals > 2 > balance Sheet > equity
29558000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-10496202
Annuals > 2 > cash Flow > depreciation
266398
Annuals > 2 > cash Flow > change In Working Capital
-507704
Annuals > 2 > cash Flow > cash From Operations
-4333167
Annuals > 2 > cash Flow > capital Expenditures
95680
Annuals > 2 > cash Flow > cash From Investing
-2089035
Annuals > 2 > cash Flow > cash From Financing
7006053
Annuals > 2 > cash Flow > net Change In Cash
583851
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.6132529253886624
Annuals > 2 > ratios > PB
0.20169020250016914
Annuals > 2 > ratios > ROE
-23.85479396440896
Annuals > 2 > ratios > ROA
-15.164419209841496
Annuals > 2 > ratios > FCF
-4428847
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-88.57694
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
50000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
3864886
Annuals > 3 > income Statement > operating Income
-3833064
Annuals > 3 > income Statement > interest Expense
15005
Annuals > 3 > income Statement > pretax Income
-3867217
Annuals > 3 > income Statement > net Income
-3867217
Annuals > 3 > income Statement > eps
-0.030890881452394162
Annuals > 3 > income Statement > dividends Per Share
410000
Annuals > 3 > income Statement > shares Outstanding
125189597
Annuals > 3 > income Statement > income Tax Expense
15005
Annuals > 3 > income Statement > EBITDA
-3763208
Annuals > 3 > income Statement > operating Margin
-7666.128000000001
Annuals > 3 > income Statement > total Other Income Expense Net
-19148
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
142196
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
113497
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
901543
Annuals > 3 > balance Sheet > property Plant Equipment
3047303
Annuals > 3 > balance Sheet > total Assets
3991775
Annuals > 3 > balance Sheet > payables
295919
Annuals > 3 > balance Sheet > short Term Debt
350000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1047869
Annuals > 3 > balance Sheet > equity
2943906
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3867217
Annuals > 3 > cash Flow > depreciation
69856
Annuals > 3 > cash Flow > change In Working Capital
-281927
Annuals > 3 > cash Flow > cash From Operations
-3249729
Annuals > 3 > cash Flow > capital Expenditures
276000
Annuals > 3 > cash Flow > cash From Investing
-42929
Annuals > 3 > cash Flow > cash From Financing
3382273
Annuals > 3 > cash Flow > net Change In Cash
89615
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.030890881452394162
Annuals > 3 > ratios > PB
22.049211504885005
Annuals > 3 > ratios > ROE
-131.36346744766988
Annuals > 3 > ratios > ROA
-96.87963374689204
Annuals > 3 > ratios > FCF
-3525729
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-70.51458
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.12063605235506193
Valuation > metrics > PB
-0.5133062240155813
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
12.448132780082988
Profitability > metrics > ROA
-160.3053435114504
Profitability > metrics > Net Margin
-81.66666666666667
Profitability > final Score
25
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
0.019083969465648856
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.03909280811698001
Liquidity > metrics > Quick Ratio
0.018416677324466044
Liquidity > final Score
11
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
40
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
12
Prev Risks > 1
-9
Prev Risks > 2
-383
Prev Liquidities > 0
12
Prev Liquidities > 1
19
Prev Liquidities > 2
23
Updated At
2026-01-20T22:00:25.844Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.12
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.18
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.11
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.36
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.3692
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS, Inc.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Impact BioMedical, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.12
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.